Glycated albumin levels are associated with adverse stroke outcomes in patients with acute ischemic stroke in China.

ABSTRACT:

Background and aim

Glycated albumin (GA) is a biomarker monitoring glycemia 2-4 weeks before stroke onset. This study was designed to explore the association between GA levels with poststroke outcomes in patients with acute ischemic stroke or transient ischemic attack (TIA).

Method

Participants with ischemic stroke or TIA who had a baseline GA measurement were included in the Third China National Stroke Registry study. The effect of GA on stroke recurrence, poor functional outcomes, and combined vascular events was examined during the 1-year follow-up period. Multivariate Cox and logistic regression models were performed to evaluate the association. Discrimination tests were used to examine the incremental predictive value of GA when incorporating it into the conventional mo

SUBMITTER: Mao J 

PROVIDER: S-EPMC11391381 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature